New study builds on significant body of evidence showing improved results using Hologic's 3D mammogram for breast cancer screening My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about HOLX BEDFORD, Mass., May 23, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography...
↧